tiprankstipranks
Linc AB (SE:LINC)
:LINC
Want to see SE:LINC full AI Analyst Report?

Linc AB (LINC) Price & Analysis

0 Followers

LINC Stock Chart & Stats

kr69.40
-kr0.60(-0.89%)
At close: 4:00 PM EST
kr69.40
-kr0.60(-0.89%)

Bulls Say, Bears Say

Bulls Say
Conservative Balance SheetEssentially no debt and a large equity base materially reduce solvency risk and give the company time and optionality to support portfolio companies, fund follow-on investments, or wait for favorable exit windows without pressure from creditors, supporting durability.
Focused Life‑science Investment ModelA clear strategic focus on long-term active ownership in medical technology, pharma/biotech and related services builds sector expertise, deal flow advantages and operational support capabilities that durablely enhance value creation potential across portfolio companies over multiple years.
Recent Revenue Rebound And Strong Gross MarginA sharp revenue rebound alongside a high gross margin demonstrates operating leverage within revenue‑generating activities and indicates the company (or its portfolio operations) can scale revenue while preserving margins, strengthening medium‑term cash generation potential when volatility eases.
Bears Say
Very Large Net LossA massive reported loss in 2025 signals material impairment, valuation write‑downs, or realization timing that erodes equity and can constrain future distributions. Such episodic large losses impair predictability of returns and can necessitate portfolio repricing or capital actions.
Uneven Cash Generation / FCF WeaknessZero FCF in 2025 and multi‑year swings in operating cash flow indicate weak and inconsistent cash conversion from operations. This reduces the firm’s ability to self‑fund exits, cover working capital needs or pursue opportunistic investments without relying on asset sales or external capital.
Business Reliant On Valuation And Realization EventsRevenue and earnings depend on timing of exits, fair value adjustments and dividend events, making performance highly cyclical and sensitive to market liquidity and biotech sector funding cycles. Structural reliance on realizations increases earnings volatility and planning uncertainty.

LINC FAQ

What was Linc AB’s price range in the past 12 months?
Linc AB lowest stock price was kr58.90 and its highest was kr83.60 in the past 12 months.
    What is Linc AB’s market cap?
    Linc AB’s market cap is kr4.17B.
      When is Linc AB’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Linc AB’s earnings last quarter?
      Currently, no data Available
      Is Linc AB overvalued?
      According to Wall Street analysts Linc AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Linc AB pay dividends?
        Linc AB does not currently pay dividends.
        What is Linc AB’s EPS estimate?
        Linc AB’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Linc AB have?
        Linc AB has 57,910,446 shares outstanding.
          What happened to Linc AB’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Linc AB?
          Currently, no hedge funds are holding shares in SE:LINC
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Linc AB

            Linc AB is a private equity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.private eequity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.

            Linc AB (LINC) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Creades AB
            Idun Industrier AB Class B
            Vo2 Cap Holding AB
            Svolder AB Class B
            MedCap AB

            Options Prices

            Currently, No data available
            ---
            Popular Stocks